Giovanni Corrao1, Arianna Ghirardi2, Buthaina Ibrahim2, Luca Merlino3, Aldo Pietro Maggioni4. 1. Dipartimento di Statistica e Metodi Quantitativi, Sezione di Biostatistica, Epidemiologia e Sanità Pubblica, Università di Milano-Bicocca, Milan, Italy. Electronic address: giovanni.corrao@unimib.it. 2. Dipartimento di Statistica e Metodi Quantitativi, Sezione di Biostatistica, Epidemiologia e Sanità Pubblica, Università di Milano-Bicocca, Milan, Italy. 3. Direzione Generale Salute, Unità Organizzativa Governo dei dati, delle strategie e piani del sistema sanitario, Regione Lombardia, Milan, Italy. 4. Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence, Italy.
Abstract
OBJECTIVE: Predictors of mortality and readmission among patients hospitalized for the first time for heart failure (HF) were investigated for a large, unselected population. METHODS: The cohort of 13,171 patients in the Lombardy Region (Italy), all of whom were aged 50years or older and survived their first hospitalization for HF during 2011, were followed after discharge. Mortality and readmission within 30days and one year of index discharge were investigated. Kaplan-Meier estimator and Cox model were respectively used to estimate the cumulative proportions of patients experiencing the outcomes and the hazard ratio (HR) for the association between selected covariates and time of outcome onset. RESULTS: Within 30days of index discharge, 4.7% and 4.3% of the cohort members died or were readmitted for HF, respectively, while 22.6% and 57.2% of them died or were readmitted for any cause within one year of index discharge. Older age was an independent predictor of mortality at both 30days and one year. One-year mortality was affected by the use of diuretics, mineralocorticoid receptor antagonists and antigout preparations and by previous hospitalization for respiratory and cerebrovascular diseases. Younger age, use of antidiabetics, diuretics, other antihypertensives, NSAIDs and antigout preparations and previous hospitalization for renal, respiratory, coronary heart and cerebrovascular disease, were independent predictors of hospital readmission. CONCLUSION: Short- and long-term mortality and readmissions after first hospitalization for HF are high and heterogeneous across different patient subgroups. Characterization of hospitalized HF is very important in assisting clinicians in decision-making and targeting treatment of high-risk patients.
OBJECTIVE: Predictors of mortality and readmission among patients hospitalized for the first time for heart failure (HF) were investigated for a large, unselected population. METHODS: The cohort of 13,171 patients in the Lombardy Region (Italy), all of whom were aged 50years or older and survived their first hospitalization for HF during 2011, were followed after discharge. Mortality and readmission within 30days and one year of index discharge were investigated. Kaplan-Meier estimator and Cox model were respectively used to estimate the cumulative proportions of patients experiencing the outcomes and the hazard ratio (HR) for the association between selected covariates and time of outcome onset. RESULTS: Within 30days of index discharge, 4.7% and 4.3% of the cohort members died or were readmitted for HF, respectively, while 22.6% and 57.2% of them died or were readmitted for any cause within one year of index discharge. Older age was an independent predictor of mortality at both 30days and one year. One-year mortality was affected by the use of diuretics, mineralocorticoid receptor antagonists and antigout preparations and by previous hospitalization for respiratory and cerebrovascular diseases. Younger age, use of antidiabetics, diuretics, other antihypertensives, NSAIDs and antigout preparations and previous hospitalization for renal, respiratory, coronary heart and cerebrovascular disease, were independent predictors of hospital readmission. CONCLUSION: Short- and long-term mortality and readmissions after first hospitalization for HF are high and heterogeneous across different patient subgroups. Characterization of hospitalized HF is very important in assisting clinicians in decision-making and targeting treatment of high-risk patients.
Authors: Roman Pfister; Peter Ihle; Birgit Mews; Elisabeth Kohnen; Marcus Wähner; Ute Karbach; Hasan Aslan; Hans-Wilhelm Höpp; Christian Alfons Schneider Journal: PLoS One Date: 2017-11-08 Impact factor: 3.240
Authors: Jacopo Lenzi; Vera Maria Avaldi; Dario Molinazzi; Carlo Descovich; Stefano Urbinati; Veronica Cappelli; Maria Pia Fantini Journal: PLoS One Date: 2019-10-28 Impact factor: 3.240
Authors: Francesca Gasperoni; Francesca Ieva; Anna Maria Paganoni; Christopher H Jackson; Linda Sharples Journal: BMC Health Serv Res Date: 2020-06-12 Impact factor: 2.655
Authors: Moritz Hadwiger; Fabian-Simon Frielitz; Nora Eisemann; Christian Elsner; Nikolaos Dagres; Gerhard Hindricks; Alexander Katalinic Journal: Appl Health Econ Health Policy Date: 2021-01 Impact factor: 2.561
Authors: Vera Maria Avaldi; Jacopo Lenzi; Stefano Urbinati; Dario Molinazzi; Carlo Descovich; Anselmo Campagna; Martina Taglioni; Angelo Fioritti; Maria Pia Fantini Journal: BMJ Open Date: 2017-11-03 Impact factor: 2.692